Crispr Therapeutics Ag · NASDAQ:CRSP

Kasinger James R. sold 10,400 Crispr Therapeutics Ag shares (Form 4)

Traded Sep 22, 2026 · Filed Sep 24, 2026

On Sep 22, 2026, Kasinger James R. (General Counsel and Secretary) sold 10,400 Crispr Therapeutics Ag shares at US$60.24 for US$626K under a trading plan, leaving 94,784 shares. Filed Sep 24, 2026 (Form 4).

Sold: 10,400 shares
Price: US$60.24
Value: US$626K
Holding after: 94,784 shares
Trading plan: Yes (Made under a plan set in advance)
Role: General Counsel and Secretary

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Sep 22, 2026	Common Shares	Option exercise	10,400	US$13.62	105,184	Direct
Sep 22, 2026	Common Shares	Sale	10,400	US$60.24	94,784	Direct

Source

View original at SEC

Related